The total effect of a microbiome is not an additive function of the individual species. These species interact in highly complex ways. Some species might normally release factors that are detrimental to health, but their behaviour is suppressed by other species present in the flora. Therefore the individual species are not of therapeutic relevance; due to limitations in our understanding, each flora must be considered as a whole.
Wanted to point out that this does not hold true for babies, where Bifidobacterium abundance generally does correlate with healthy microbiota and the strain B. infantis is relevant therapeutically and has evolved to metabolize milk sugars into short chain fatty acids.
The point here is that individual strains are only "beneficial" in so far as they interact positively with others.
In essence, a randomised controlled trial looked at the effects of gut microbiome modulation on muscle function and cognition in older adults. Participants in the trail received either a prebiotic or a placebo.
My takeaways: - The prebiotic improved cognitive function, but not muscle function, for members of the trial.
- The gut microbiome composition changed in the prebiotic group, with an increase in Bifidobacterium abundance. (Was not clear on a first read if that is necessarily always positive).
- The trial suggests that microbiome modulation might be a target for improving cognitive function in older adults.
- Prebiotics the trial mentions: inulin and FOS